- 期刊
Outpatient-Based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
延伸閱讀
- Kanbe, K., Chiba, J., Inoue, Y., Taguchi, M., Yabuki, A., & Deguchi, T. (2016). Simultaneous Treatment with Subcutaneous Injection of Golimumab and Intra-articular Injection of Triamcinolone Acetonide (K-Method) in Patients with Rheumatoid Arthritis Undergoing Switching of Biologics: Retrospective Case-Control Study. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, (2016), 45-49. https://doi.org/10.4137/CMAMD.S38442
- Hammoudeh, M., Awadhi, A. A., Hasan, E. H., Akhlaghi, M., Ahmadzadeh, A., & Abdollahi, B. S. (2015). Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East. International Journal of Rheumatology, 2015(), 136-142. https://doi.org/10.1155/2015/975028
- Eisfeld, A. K., Westerman, M., Krahl, R., Leiblein, S., Liebert, U. G., Hehme, M., Teupser, D., Niederwieser, D., & Ali, H. K. A. (2011). Highly Elevated Serum Hepcidin in Patients with Acute Myeloid Leukemia prior to and after Allogeneic Hematopoietic Cell Transplantation: Does This Protect from Excessive Parenchymal Iron Loading?. Advances in Hematology, 2011(), 192-199. https://doi.org/10.1155/2011/491058
- Zhu, D. L., Gao, P. J., Yagi, N., & Schumacher, H. (2014). Efficacy and Tolerability of Telmisartan Plus Amlodipine in Asian Patients Not Adequately Controlled on Either Monotherapy or on Low-Dose Combination Therapy. International Journal of Hypertension, (2014), 48-58. https://doi.org/10.1155/2014/475480
- Tsai, M. H., Li, T. H., Lai, C. C., Chen, W. S., & Tsai, C. Y. (2017). The long-term efficacy and safety of tocilizumab in younger and elderly patients with refractory rheumatoid arthritis: A single tertiary-center cohort study. Formosan Journal of Rheumatology, 31(2), 22-29. https://doi.org/10.6313/FJR.201712_31(2).0004